Appendix I: Bulk Drugs List
TABLE OF CONTENTS
This Appendix contains for each of the nominated substances:
1.
The cover sheet provided by
the nominator. This includes general information about the substance,
including its chemical properties.
2.
Selected abstracts of articles
obtained by FDA from the medical literature attesting to the use of the
substance. These are a sampling of articles identified through searches of
Medline, Toxline, IRIS, and International Pharmaceutical Abstracts.
3.
A summary of the toxicological
data for the substance prepared by FDA after review of the literature.
A bibliography prepared by FDA of articles
identified through a search of the medical literature concerning the
substance. This bibliography is not exhaustive.
NOMINATED
SUBSTANCES
2. Betahistine
Dihydrochloride
5.
Cantharidin
7.
Cyclandelate
10. Dimercapto-1-Propanesulfonic
Acid
14.
Glutamine
15.
Guaiacol
17.
lodoform
22. Phenyltoloxamine
Dihydrogen Citrate
23.
Piracetam
25.
Sodium Butyrate
26.
Sulfadimethoxine
27.
Taurine
28.
Thymol Iodide
29.
Tinidazole
The
following additional substances were nominated but are already the subject of a
USP/NF monograph and/or components of approved drugs. Under the Federal Food,
Drug, and Cosmetic Act as amended by section 127 of the Modernization Act,
these may already be used in pharmacy compounding and, therefore, are not
included in the documentation or proposed for inclusion on the list:
1. Clotrimazole
2.
Fluocinonide
3.
Hydrocortisone
4.
Hydroquinone
5.
Pramoxine
6.
Quinacrine
Hydrochloride
7.
Salicylic
Acid
8.
Tretinoin
9. Triamcinolone